FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312114328> ?p ?o ?g. }

• W4312114328 endingPage "1135" @default.
• W4312114328 startingPage "1130" @default.
• W4312114328 abstract "JJM has received grants from MSD, Novo Nordisk and Sanofi; and lecture/other fees from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, MSD, Novo Nordisk, Sanofi and Servier. EM reports serving on scientific advisory boards; and consulting for, lecturing for and/or receiving research grants from Eli Lilly, Menarini, MSD, Novo Nordisk, Roche and Sanofi. REP reports lecture and consulting fees from AstraZeneca; consulting fees from Boehringer Ingelheim, Eisai, GlaxoSmithKline and Mundipharma; grants, lecture and consulting fees from Glytec, Janssen, Novo Nordisk, Pfizer and Takeda; grants from Lexicon Pharmaceuticals; and grants and consulting fees from Ligand Pharmaceuticals, Lilly, Merck and Sanofi-Aventis US outside of the submitted work. REP's fees for services were paid directly to AdventHealth, a non-profit organization. AYYC reports honoraria from Abbott, Amgen, AstraZeneca, Bausch, Bayer, Boehringer Ingelheim, Dexcom, Eli Lilly, GlaxoSmithKline, HLS Therapeutics, Insulet, Janssen, Medtronic, Merck, Novo Nordisk, Pfizer, Sanofi and Takeda. LB, BM and LW are employees, and LB and LW are shareholders, of Novo Nordisk A/S. The peer review history for this article is available at https://publons.com/publon/10.1111/dom.14957. Data are available upon reasonable request. Data will be shared with bona fide researchers submitting a research proposal approved by the independent review board. Access request proposals can be found at novonordisk-trials.com. Data will be made available after research completion, and approval of the product and product use in the European Union and the USA. Individual participant data will be shared in data sets in a de-identified/anonymized format. TABLE S1. Mean change from baseline in body weight (kg) by presence or absence of GI AEs at the end of treatment. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article." @default.
• W4312114328 created "2023-01-04" @default.
• W4312114328 creator A5002832666 @default.
• W4312114328 creator A5008813435 @default.
• W4312114328 creator A5011764644 @default.
• W4312114328 creator A5014306017 @default.
• W4312114328 creator A5031060251 @default.
• W4312114328 creator A5059098934 @default.
• W4312114328 creator A5077698665 @default.
• W4312114328 date "2023-01-17" @default.
• W4312114328 modified "2023-10-09" @default.
• W4312114328 title "Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis" @default.
• W4312114328 cites W2077496630 @default.
• W4312114328 cites W2163229244 @default.
• W4312114328 cites W2344263484 @default.
• W4312114328 cites W2550011910 @default.
• W4312114328 cites W2563047690 @default.
• W4312114328 cites W2593691145 @default.
• W4312114328 cites W2761182291 @default.
• W4312114328 cites W2808271763 @default.
• W4312114328 cites W2922550132 @default.
• W4312114328 cites W2948370538 @default.
• W4312114328 cites W2948380809 @default.
• W4312114328 cites W2948622224 @default.
• W4312114328 cites W2951522032 @default.
• W4312114328 cites W2974621372 @default.
• W4312114328 cites W2974714926 @default.
• W4312114328 cites W3013242926 @default.
• W4312114328 cites W3041477129 @default.
• W4312114328 cites W3106528346 @default.
• W4312114328 cites W3199001556 @default.
• W4312114328 cites W4200607853 @default.
• W4312114328 doi "https://doi.org/10.1111/dom.14957" @default.
• W4312114328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36562481" @default.
• W4312114328 hasPublicationYear "2023" @default.
• W4312114328 type Work @default.
• W4312114328 citedByCount "2" @default.
• W4312114328 countsByYear W43121143282023 @default.
• W4312114328 crossrefType "journal-article" @default.
• W4312114328 hasAuthorship W4312114328A5002832666 @default.
• W4312114328 hasAuthorship W4312114328A5008813435 @default.
• W4312114328 hasAuthorship W4312114328A5011764644 @default.
• W4312114328 hasAuthorship W4312114328A5014306017 @default.
• W4312114328 hasAuthorship W4312114328A5031060251 @default.
• W4312114328 hasAuthorship W4312114328A5059098934 @default.
• W4312114328 hasAuthorship W4312114328A5077698665 @default.
• W4312114328 hasBestOaLocation W43121143281 @default.
• W4312114328 hasConcept C512399662 @default.
• W4312114328 hasConcept C71924100 @default.
• W4312114328 hasConceptScore W4312114328C512399662 @default.
• W4312114328 hasConceptScore W4312114328C71924100 @default.
• W4312114328 hasIssue "4" @default.
• W4312114328 hasLocation W43121143281 @default.
• W4312114328 hasLocation W43121143282 @default.
• W4312114328 hasOpenAccess W4312114328 @default.
• W4312114328 hasPrimaryLocation W43121143281 @default.
• W4312114328 hasRelatedWork W1506200166 @default.
• W4312114328 hasRelatedWork W1995515455 @default.
• W4312114328 hasRelatedWork W2048182022 @default.
• W4312114328 hasRelatedWork W2080531066 @default.
• W4312114328 hasRelatedWork W2604872355 @default.
• W4312114328 hasRelatedWork W2748952813 @default.
• W4312114328 hasRelatedWork W2899084033 @default.
• W4312114328 hasRelatedWork W3031052312 @default.
• W4312114328 hasRelatedWork W3032375762 @default.
• W4312114328 hasRelatedWork W3108674512 @default.
• W4312114328 hasVolume "25" @default.
• W4312114328 isParatext "false" @default.
• W4312114328 isRetracted "false" @default.
• W4312114328 workType "article" @default.